2002
DOI: 10.1159/000051820
|View full text |Cite
|
Sign up to set email alerts
|

Sweet’s Syndrome Induced by Oral Contraceptive

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
8
0

Year Published

2002
2002
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 5 publications
(6 reference statements)
0
8
0
Order By: Relevance
“…Sweet's syndrome has also been linked to the oral contraceptive pill. 6 The association that we found with the Mirena IUS adds weight to this hypothesis. It also serves to highlight the importance of detailed clinical history taking in patients with dermatological signs, particularly with regard to hormonal contraception and implants/prostheses.…”
Section: Case Reportmentioning
confidence: 52%
“…Sweet's syndrome has also been linked to the oral contraceptive pill. 6 The association that we found with the Mirena IUS adds weight to this hypothesis. It also serves to highlight the importance of detailed clinical history taking in patients with dermatological signs, particularly with regard to hormonal contraception and implants/prostheses.…”
Section: Case Reportmentioning
confidence: 52%
“…The implicated medications were trimethoprim–sulphamethoxazole 1,2 (two subjects), ethinyl oestradiol and levonorgestrel 3 (one subject), minocycline 4 (two subjects), all‐ trans ‐retinoic acid 5 (seven subjects), granulocyte colony‐stimulating factor 6 (30 subjects), hydralazine 7 (two subjects), diclofenac 8 (one subject), carbamazepine 9 (one subject) and nitrofurantoin 10 (one subject). In addition we reported the first known case of diazepam‐induced Sweet's syndrome 11 and the second case of Sweet's syndrome associated with an oral contraceptive containing ethinyl oestradiol and gestodene 12 . The age of the subjects with drug‐induced Sweet's syndrome ranged from 5 to 75 years (mean age, 47 years), and the majority were women (32 of 49).…”
mentioning
confidence: 98%
“…On the other hand, the pregnant woman presents progressive neutrophilia during gestation which leads to a situation of major inflammation facilitating the work [2]. The role of hormonal factors could also be raised because of the induction of neutrophilic dermatoses such as Sweet's syndrome by oral contraceptives or their occurrence during pregnancy [15]. The treatment of the PSPG is not unique and is identical to that of the PG occurring de novo.…”
Section: Discussionmentioning
confidence: 99%